Literature DB >> 12140221

Successful treatment of squamous cell carcinoma of the lower eyelid with intralesional cidofovir.

D Calista, L Riccioni, L Coccia.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12140221      PMCID: PMC1771246          DOI: 10.1136/bjo.86.8.932

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  9 in total

1.  Cidofovir for the treatment of Kaposi's sarcoma in an HIV-negative homosexual man.

Authors:  K Fife; J Gill; D Bourboulia; B Gazzard; M Nelson; M Bower
Journal:  Br J Dermatol       Date:  1999-12       Impact factor: 9.302

2.  Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).

Authors:  R Snoeck; J C Noel; C Muller; E De Clercq; M Bossens
Journal:  J Med Virol       Date:  2000-02       Impact factor: 2.327

3.  Antitumor potential of acyclic nucleoside phosphonates.

Authors:  E De Clercq; G Andrei; J Balzarini; S Hatse; S Liekens; L Naesens; J Neyts; R Snoeck
Journal:  Nucleosides Nucleotides       Date:  1999 Apr-May

Review 4.  Basal cell carcinoma--new aspects of diagnosis and treatment.

Authors:  A M Wennberg
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  2000

5.  Intralesional cidofovir for recurrent respiratory papillomatosis in children.

Authors:  S M Pransky; A E Magit; D B Kearns; D R Kang; N O Duncan
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1999-10

6.  Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.

Authors:  E De Clercq
Journal:  Verh K Acad Geneeskd Belg       Date:  1996

Review 7.  Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.

Authors:  E J Zabawski; C J Cockerell
Journal:  J Am Acad Dermatol       Date:  1998-11       Impact factor: 11.527

8.  Potent inhibition of hemangioma formation in rats by the acyclic nucleoside phosphonate analogue cidofovir.

Authors:  S Liekens; G Andrei; M Vandeputte; E De Clercq; J Neyts
Journal:  Cancer Res       Date:  1998-06-15       Impact factor: 12.701

9.  Successful treatment of a squamous papilloma of the hypopharynx-esophagus by local injections of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.

Authors:  E Van Cutsem; R Snoeck; M Van Ranst; P Fiten; G Opdenakker; K Geboes; J Janssens; P Rutgeerts; G Vantrappen; E de Clercq
Journal:  J Med Virol       Date:  1995-02       Impact factor: 2.327

  9 in total
  3 in total

1.  Standardised clinical photography in ophthalmic plastic surgery.

Authors:  M S Bajaj; N Pushker; A Mahindrakar; R Balasubramanya
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

Review 2.  Clinical potential of the acyclic nucleoside phosphonates cidofovir, adefovir, and tenofovir in treatment of DNA virus and retrovirus infections.

Authors:  Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

3.  The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.

Authors:  Sandra Liekens; Sam Noppen; Sofie Gijsbers; Rebecca Sienaert; Roberto Ronca; Chiara Tobia; Marco Presta
Journal:  Oncotarget       Date:  2015-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.